Device Uromax Ultra_uro

Uromax Ultra

Payments companies reported to CMS as associated with Uromax Ultra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$28Kassociated payments (2023-2025)
9clinicians with associated payments
1company reporting

By year

2023 $12K
2024 $17K
2025 $15.53

Payments reported as associated with Uromax Ultra, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $23K
Obstetrics & Gynecology $4,844
Urology $35.10
Family $19.57

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Uromax Ultra

These are the largest totals companies reported as associated with Uromax Ultra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Charbel Salamon Orlando, FL Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $7,201.70
Thomas Giudice West Columbia, SC Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $6,618.60
Michael Swan Nashville, TN Obstetrics & Gynecology $4,843.71
C Bowling Knoxville, TN Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $4,544.31
Savitha Krishnan Mountain View, CA Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $4,166.76
Katarzyna Bochenska Park Ridge, IL Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $900.00
Michelle Semins Pittsburgh, PA Urology $19.57
Noelle Brossman Wheeling, WV Family $19.57
Ryan Turpen Danville, KY Urology $15.53

Prescribed Uromax Ultra?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.